Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03611231
What this trial is testing

Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

Who this might be right for
Experimental Tumor
Peking University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07463807
What this trial is testing

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
National Cancer Institute (NCI) 162
Large-scale testing (Phase 3)Study completedNCT00003212
What this trial is testing

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 780
Testing effectiveness (Phase 2)Looking for participantsNCT06136546
What this trial is testing

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Who this might be right for
Depressive Disorder, MajorInflammation
Massachusetts General Hospital 100
Not applicableActive Not RecruitingNCT06090162
What this trial is testing

LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin Lymphoma, B Cell
Swiss Cancer Institute 64
Testing effectiveness (Phase 2)Study completedNCT01282463
What this trial is testing

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

Who this might be right for
Carcinoma of Urinary TractUrethral CarcinomaCarcinoma of Ureter+1 more
Eli Lilly and Company 148
Not applicableWithdrawnNCT00877617
What this trial is testing

Quality of Life in Men With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT00127101
What this trial is testing

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 23
Not applicableUnknownNCT04857749
What this trial is testing

Navigation on Head and Neck Radiotherapy

Who this might be right for
Head and Neck Cancer
Selcuk University 68
Not applicableStudy completedNCT04007081
What this trial is testing

Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia

Who this might be right for
XerostomiaHead and Neck Cancer
University of Wisconsin, Madison 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Testing effectiveness (Phase 2)UnknownNCT03617432
What this trial is testing

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

Who this might be right for
Experimental Tumor
Peking University 114
Large-scale testing (Phase 3)UnknownNCT00122746
What this trial is testing

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

Who this might be right for
Cancer of the Cervix
International Atomic Energy Agency 322
Testing effectiveness (Phase 2)Looking for participantsNCT07479979
What this trial is testing

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Natalie Callander 62
Not applicableStudy completedNCT07582666
What this trial is testing

Identifying and Mobilizing Personal Resources to Improve Well-Being in Cancer Participants Using the CAERES Protocol

Who this might be right for
Self EfficacyNeoplasms (Cancer / Tumors)Cancer-related Fatigue+4 more
UniDistance Suisse 32
Testing effectiveness (Phase 2)WithdrawnNCT01349088
What this trial is testing

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancerStage IV Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableEnded earlyNCT03465579
What this trial is testing

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

Who this might be right for
68Ga-PSMA PET/CT Guided Prostate BiopsyMp-3TMRI Guided Prostate BiopsyProstate Cancer+2 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 261
Not applicableStudy completedNCT06395896
What this trial is testing

The Effect of Breast Cancer Prevention Journey Program

Who this might be right for
Breast Cancer Female
Nurbanu Odacı 70
Testing effectiveness (Phase 2)Study completedNCT03994601
What this trial is testing

An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 219
Early research (Phase 1)Study completedNCT00414336
What this trial is testing

Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 150
Next Page